Abstract
New gene-editing technologies, like CRISPR, promise revolutionary advances in biology and medicine. However, several patent disputes in the USA and UK may have complicated who can use CRISPR. What does this mean for the future of gene editing?. June 2016.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 26-29 |
| Number of pages | 4 |
| Journal | Biochemist |
| Volume | 38 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2016 |
| Externally published | Yes |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'Who owns gene editing? Patents in the time of CRISPR'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS